BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study

Trial Profile

BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study

Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Jul 2016

At a glance

  • Drugs Ridaforolimus (Primary)
  • Indications Coronary artery disease; Heart disorders
  • Focus Pharmacokinetics
  • Acronyms BIONICS
  • Sponsors Medinol
  • Most Recent Events

    • 03 Jul 2016 Status changed from not yet recruiting to recruiting.
    • 15 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top